Gilead Sciences Partners with Unite for HER to Support Metastatic Breast Cancer Patients

Gilead Sciences, Inc. has joined forces with Unite for HER (UFH) to launch the Metastatic Breast Cancer Sustainer Program, a groundbreaking initiative aimed at providing free integrative care to Black, Hispanic, and underserved metastatic breast cancer patients across the United States. This program offers a range of services including acupuncture, counseling, nutrition support, and fitness memberships, all at no cost to the patient.

Sue Weldon, Founder and CEO of Unite for HER, highlighted the program's impact, noting its role as a lifeline for many patients, particularly those from marginalized communities. The initiative not only supports patients in adhering to their treatment plans but also significantly improves their quality of life by addressing the whole person.

Carmen Villar, Senior Vice President of Global Giving, Advocacy, and Responsibility at Gilead Sciences, emphasized the company's commitment to innovative solutions that meet the specific needs of the metastatic breast cancer community. This partnership underscores Gilead's dedication to making a measurable difference in the lives of patients through accessible, comprehensive care.

Since its inception in October 2023, the program has already benefited over 2,823 patients, with Gilead's funding enabling a focused effort to reach Black, Hispanic, and underserved populations. For more information on the program and its services, visit https://www.uniteforher.org.